Seeking Alpha

Hepatitis C-related stocks look set to be on the radar of traders as data gets dumped fast and...

Hepatitis C-related stocks look set to be on the radar of traders as data gets dumped fast and furious out of a EASL meeting in Europe. One early casualty is Achillion Pharmaceuticals (ACHN), down 4.4% premarket, after Bristol-Myers Squibb and Gilead Sciences report positive results for GS-7977 and see shares rise. Other Hep-C players: IDIX +0.7% premarket, BCRX and VRTX inactive.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|